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Understanding gut microbiota alterations associated
with HIV infection and factors that drive these alter-
ations may help explain gut-linked diseases preva-
lent with HIV. 16S rRNA sequencing of feces from
HIV-infected individuals revealed that HIV infection
is associated with highly characteristic gut commu-
nity changes, and antiretroviral therapy does not
consistently restore the microbiota to an HIV-nega-
tive state. Despite the chronic gut inflammation char-
acteristic of HIV infection, the associated microbiota
showed limited similarity with other inflammatory
states and instead showed increased, rather than
decreased, diversity. Meta-analysis revealed that
the microbiota of HIV-infected individuals in the
U.S. was most similar to a Prevotella-rich community
composition typically observed in healthy individuals
in agrarian cultures of Malawi and Venezuela and
related to that of U.S. individuals with carbohy-
drate-rich, protein- and fat-poor diets. By evaluating
innate and adaptive immune responses to lysates
from bacteria that differ with HIV, we explore the
functional drivers of these compositional differ-
ences.
INTRODUCTION
HIV-1 infection induces rapid and substantial damage to gut-
associated lymphoid tissues (GALTs), with massive depletion
of Th17 cells, a subset of CD4+ T cells that control intestinal bac-
teria (Brenchley et al., 2004). Loss of this CD4+ T cell subset may
facilitate disease progression by allowing translocation of bacte-
rial products such as lipopolysaccharide to blood, causing sys-
temic T cell activation (Brenchley et al., 2006).
In healthy individuals, intestinal bacteria help control harmful
pathogens, educate the immune system, and aid in digestion
(Lozupone et al., 2012), but distinctive compositions of this com-
plex community have been associated with pathologies that are
of increased prevalence with HIV infection, including metabolic
disorders (Madge et al., 1999; Vijay-Kumar et al., 2010), chronic
inflammation (Bjarnason et al., 1996; Willing et al., 2010),
wasting/malnutrition (Smith et al., 2013; Wanke et al., 2000),Cell Host & Matherosclerosis (Hsue et al., 2009; Koeth et al., 2013), and sus-
ceptibility to opportunistic infections (Chang et al., 2008).
Considering the important role that both innate and adaptive im-
munity play in shaping gut microbiota composition (Carvalho
et al., 2012; Hepworth et al., 2013), understanding how compo-
sition differs with HIV infection, immunologic driving factors of
these differences, and their implication for gut-linked diseases
that increase in prevalence with HIV is of paramount importance.
Using 16S rRNA sequencing of feces, we show that HIV infec-
tion is associated with highly characteristic changes in gut com-
munity structure and that antiretroviral therapy (ART) does not
consistently restore the microbiota to an HIV-negative like state.
Using meta-analysis, we demonstrate that although the HIV-
associated microbiota bears some resemblance to that of other
chronic inflammatory states, the differences between HIV-asso-
ciated and healthy gut microbiota are also related to composi-
tional changes previously associated with diet (Wu et al., 2011)
and Western compared to agrarian cultures (De Filippo et al.,
2010; Yatsunenko et al., 2012), suggesting an interplay between
diet and the immune system in shaping gut microbiota composi-
tion. By comparing T cell proliferation and cytokine responses to
lysates from bacteria that differ with HIV infection in blood from
HIV-positive and -negative individuals, we begin to explore the
relationship between immune dysfunction and HIV-associated
microbiota change.RESULTS
Stool Microbiota in Chronic Untreated HIV Infection Is
Distinctive
We sequenced the V4 region of 16S rRNA genes from fecal sam-
ples of individuals with chronic HIV infection (n = 22), recent
infection (n = 3), and HIV-negative controls (n = 13) (Table 1,
see Table S1 online). Eleven individuals with chronic infection
had not recently undergone ART, and eight had been on ART
for R12 months with viral suppression for R6 months (see the
Experimental Procedures for further cohort details). Individuals
were excluded during recruitment if they were pregnant,
weighed <110 pounds, or had received antibiotics within the
prior 30 days, resulting in inclusion of only relatively healthy
HIV-positive subjects; no chronically HIV-infected individual
had a peripheral CD4+ T cell count below 204 cells/ml (Table 1).
Principal Coordinates Analysis (PCoA) of fecal samples based
on 16S rRNA sequences using both unweighted (Figure 1) and
weighted (Figure S1) UniFrac showed a strong difference inicrobe 14, 329–339, September 11, 2013 ª2013 Elsevier Inc. 329
Table 1. Description of Cohorts
Cohort N
Age
(Years)
Sex (M, Male;
F, Female)
Race
BMI
Duration
ART (Months)
CD4
(Cells/mL)
Viral Load
(Copies/mL)W Wh AA AI ?
1: Recent HIV infection 3 31 ± 4.36 M, 2; F, 1 3 0 0 0 0 32.5 ± 8.30 0 614 ± 521.8
(107–1,342)
164,880 ± 210,225
(418–449,000)
2: Chronic HIV untreated 11 30 ± 5.61 M, 11; F, 0 6 2 2 1 0 25.0 ± 4.83 0 551 ± 218.2
(270–1095)
139,109 ± 255,929
(1,350–869,000)
2*: Chronic HIV short-term
ART
6a 34 ± 10.27 M, 5; F, 1 3 2 1 0 0 27.1 ± 3.67 7.68 ± 0.78 609 ± 50.6
(547–681)
83 ± 105.0
(39–247)
3: Chronic HIV long-term ART 8 45 ± 8.30 M, 7; F, 1 5 2 1 0 0 24.7 ± 6.45 33.6 ± 17.97 483 ± 258.0
(204–876)
124 ± 280.8
(<20–819)
4: HIV-seronegative 13 37 ± 12.26 M, 8; F, 5 10 1 1 0 1 25.6 ± 3.03 0 NA 0
Race abbreviations are W (white, not Hispanic), Wh (white-Hispanic), AA (African American), AI (American Indian), and ? (unknown). See also Table S1.
Values are given as mean ± SD with ranges in parentheses.
aThree of the six individuals in cohort 2* are also in cohort 2 because they were sampled both before and after short-term ART treatment.
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compared to HIV-negative controls. UniFrac evaluates micro-
biota similarity based on shared evolutionary history of bacterial
taxa, and theweightedmetric differs from unweighted because it
accounts for change in relative abundance in addition to pres-
ence or absence (Lozupone and Knight, 2005; Lozupone et al.,
2007). Fecal microbiota with chronic untreated HIV infection
also had greater overall diversity, with higher evenness as
measured by the Shannon diversity index (p = 0.013) and rich-
ness as measured by phylogenetic diversity (PD) (p = 0.0003)
(Table 2).
To further determine the degree to which gut microbiota with
chronic untreated infection differed from HIV-negative controls,
we used a supervised learning technique called Random Forests
(Knights et al., 2011a). The purpose of the Random Forests clas-
sifier is to learn a function that maps a set of predictive features
to a discrete state, in this case healthy versus chronically in-
fected with HIV and without ART. We used as features the rela-
tive abundance in each sample of 97% identity (ID) Operational
Taxonomic Units (OTUs; clusters in which sequences have
R97% identity over their aligned 16S rRNA genes, which
approximates assignment to the same species; Stackebrandt
and Goebal, 1994). The measure of the method’s success is its
ability to classify new samples as coming from an HIV-positive
or -negative individual. We only used one sample per individual
when multiple time points were collected. The model could clas-
sify unknown samples according to HIV status with a 4.33% ±
0.821% error rate, which is 10.6 times higher than the baseline
error rate for random guessing of 45.83%, indicating that HIV-
associated microbiota exhibit highly characteristic differences.
To investigate whether disease severity impacted gut micro-
biota in HIV infection, we determined whether microbiota diver-
sity correlated with peripheral CD4+ T cell count or plasma HIV-1
RNA viral load in 11 individuals with chronic infection who were
not on ART. As an estimate of divergence from healthy, we
calculated the average pairwise weighted and unweighted Uni-
Frac distance between each HIV microbiota sample and HIV-
negative control samples. The magnitude of divergence from
HIV-negative microbiota samples was not correlated with
CD4+ T cell count or plasma HIV-1 RNA viral load (all Spearman
correlation p values > 0.73).330 Cell Host & Microbe 14, 329–339, September 11, 2013 ª2013 ElIndividuals Recently Infected with HIV Have Relatively
Subtle Microbiota Differences
Themicrobiota of recently infected untreated individuals differed
little from uninfected controls. Samples from two of three
recently infected individuals clustered in an intermediate position
between healthy and untreated chronic infection in an un-
weighted UniFrac PCoA plot (Figure 1A). However, these individ-
uals clustered with chronically infected subjects when using
weighted UniFrac (Figure S1), suggesting that changes in relative
abundance of existing taxa may occur faster than gain or loss of
taxa.
Effects of ART Treatment
No chronically infected individual sampled pre and post 6.7–
8.5 months of ART exhibited a strong shift toward the HIV-nega-
tive individuals (Figure 1A), indicating that short-term ART was
insufficient to restore the microbiota. However, the microbiota
of two individuals treated for 7.1–8.5 months for whom we did
not collect pre-ART samples showed a closer resemblance to
HIV-negative individuals than to subjects with untreated chronic
HIV-1 infection (Figure 1B). Of the eight HIV-chronic individuals
on long-term ART (12.1–57.6 months), five clustered with un-
treated chronically infected individuals, and three clustered
with HIV-negative individuals (Figure 1B). Individuals on ART
for as long as 57.6 months could still cluster with HIV-positive
subjects with chronic infection, indicating that ART duration
alone does not predict restoration to a HIV-negative phenotype.
Untreated HIV-infected individuals had significantly higher alpha
diversity (PD and evenness) compared to ART-treated and HIV-
negative individuals, which were not significantly different from
each other (Table 2).
Taxa that Discriminate between HIV-Negative
Individuals and Chronic HIV Infection
The fecal microbiota of untreated individuals with chronic infec-
tion exhibited significantly higher relative abundances of Prevo-
tellaceae (Prevotella), Erysipelotrichaceae (Catenibacterium and
Bulleidia), Veillonellaceae (Dialister andMitsuokella), Clostridium
cluster XIII, and the genus Desulfovibrio compared to HIV
negative (Figure 1, Figure 2, Table S2). HIV-negative individuals
had increased Bacteroidaceae (Bacteroides), Rikenellaceaesevier Inc.
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Figure 1. Unweighted UniFrac Clustering of HIV Data Set
Each point represents a single fecal sample. (A) and (B) represent the same PCoA analysis but for clarity, (A) only shows HIV-positive individuals not on ART at the
time of initial sample collection and HIV-negative controls, and (B) shows only HIV-positive individuals on ART. Points are labeled with ART duration at the time of
sample collection in months. Samples from the same individual at two time points are joined with a line. Bacterial families are plotted as a weighted average of the
coordinates of all samples, where the weights are the relative abundances of the taxon in the samples (gray circles). The size of the sphere representing a taxon is
proportional to the mean relative abundance of the taxon across samples. See Figure S1 for results with Weighted UniFrac.
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Gut Microbiota Alterations with HIV-1 Infection(Alistipes), and Porphyromonadaceae (Parabacteroides) (Fig-
ure 1, Figure 2, Table S2).
To identify 97% ID OTUs that differentiate individuals with
chronic HIV infection from HIV-negative controls, we used the
discriminative OTU features from the Random Forests classifier
(see the Experimental Procedures). Random Forests assigns
an importance score to each OTU by estimating the increase
in error caused by removing that OTU from the set of predictors.
Discriminative OTUs depleted in HIV infection subjects were
highly related (>97% ID) to type species in the families
Bacteroidaceae (Bacteroides uniformis/fluxus, Bacteroides xyla-
nisolvens, Bacteroides finegoldii, Bacteroides thetaiotaomicron,
and Bacteroides massiliensis), Rikenellaceae (Alistipes putridi-
nis), and Porphyromonadaceae (Parabacteroides distasonis)
(Table S2). Species highly related to OTUs that increased
in relative abundance with HIV infection included species
in the families Erysipelotrichaceae (Eubacterium biforme,
Catenibacterium mitsuoki), Prevotellaceae (Prevotella copri and
Prevotella stercorea), Veillonellaceae (Dialister propionicifaciens,
Mitsuokella jalaludinii, Allisonella histaminiformans, Mega-
sphaera elsdenii, and Acidaminococcus fermentans), Rumino-
coccaceae (Ruminococcus callidus), and Desulfovibrionaceae
(Desulfovibrio piger) (Table S2).
The identification of discriminatory 97% ID OTUs closely
related to readily obtainable type species allows for investigation
of immunologic driving factors of HIV-associated microbiota
changes. However, since differences in biological attributes
can occur even at the strain level (e.g., consider enterotoxic
versus commensal Escherichia coli), we determined whether
OTUs that change with HIV infection are related in phylogenetic
lineages. Type species in lineages with a broad conservation of
HIV-associated change are more likely to share the traits thatCell Host & Mdrove HIV association. A positive association with HIV was
broadly conserved across the Prevotellaceae but particularly in
a lineage containing P. copri and P. stercorea (Figure S2A). An
HIV-negative association was conserved across the Bacteroides
genus (Figure S2A).
Evaluating the HIV-Associated Community Type in a
Broader Context
Since HIV-positive individuals suffer from increased incidence of
diarrhea in the absence of obvious enteric pathogens and
increased intestinal inflammation (Bjarnason et al., 1996;
Brenchley and Douek, 2008), we had expected an expansion
of bacteria that increase with other chronic intestinal inflamma-
tory diseases. We were thus surprised that the most obvious
compositional difference was an expansion of Prevotella and
decrease in Bacteroides. To our knowledge, Prevotella had
never before been described to be particularly proinflammatory,
but Prevotella-rich/Bacteroides-poor gut microbiota had been
observed in healthy individuals living in agrarian societies in Bur-
kina Faso (De Filippo et al., 2010) and in Malawi and Venezuela
(Yatsunenko et al., 2012), and in U.S. adults who consumed diets
poor in animal protein and saturated fats and rich in carbohy-
drates (as assessed over the prior year with a food frequency
questionnaire) (Wu et al., 2011). Since Prevotella and Bacter-
oides are only two genera in the very complex gut community,
we wanted to determine whether Prevotella enrichment in HIV
infection is an indicator for the same complex combinations of
co-occurring taxa of Prevotella-rich microbiota in health. We
thus combined this study’s data with data from (1) a survey of
fecal microbiota in individuals from Malawi, the Amazonas State
of Venezuela, and the U.S. (Yatsunenko et al., 2012) and (2) a
study linking long-term dietary patterns in healthy U.S. adultsicrobe 14, 329–339, September 11, 2013 ª2013 Elsevier Inc. 331
Table 2. Comparison of Alpha Diversity in HIV-Positive and
-Negative Individuals with and without ART Treatment
Observed
Species Shannon PD
HIV negative 508 ± 21.6 5.6 ± 0.19 27.9 ± 1.46
Chronic HIV, ART untreated 563 ± 30.5 6.3 ± 0.15 36.4 ± 1.31
Chronic HIV on long-term
ART
469 ± 39.6 5.68 ± 0.16 28.69 ± 1.19
Recent HIV 517 ± 64.4 5.76 ± 0.49 31.7 ± 3.06
p value (ART untreated
versus negative) t test
0.144 0.013 0.0003
p value (ART untreated
versus ART treated) t test
0.070 0.016 0.0006
Values are given as mean ± SD.
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2011).
PCoA clustering with unweighted UniFrac was largely driven
by technical variation between studies (Figure 3A), as might be
expected since they varied methodologically (Table S3) (Lozu-
pone et al., 2013). However, by coloring the points by the relative
abundance of Bacteroides (Figure 3B) and Prevotella (Figure 3C),
it is clear that the major diversity differences within all three data
sets are associated with a tradeoff between these genera along
the same axis of variation. Samples fromHIV-positive individuals
from the U.S. clustered closer to individuals from Malawi and
Venezuelan Amerindians than to HIV-negative individuals from
the U.S. (Figure 3D). Additionally, the discriminative 97% ID
OTUs that differentiated adults from Western and agrarian cul-
tures using Random Forests analysis (Yatsunenko et al., 2012)
were highly related and sometimes identical to those that
discriminated between HIV-negative and -positive individuals
(Figure S2). This was particularly evident for the Bacteroidales
order, where Western and HIV-negative associated OTUs clus-
tered together in the Bacteroides and Alistipes genera and
agrarian and HIV-positive associated OTUs clustered together
in the Prevotella genus (Figure S2A). However, consistent with
the notion that Bacteroides and Prevotella are indicator taxa
for more complex community assemblages, parallels between
agrarian cultures and HIV-positive individuals were also
observed in other taxonomic groups (see Figure S2 for more
details).
Since HIV infection induces chronic gut inflammation (Bjarna-
son et al., 1996; Brenchley and Douek, 2008), we also used
meta-analysis to determine whether there is a relationship with
a chronic inflammatory disease of the gut using data from fecal
samples collected from individuals with Crohn’s disease and
healthy controls in Willing et al. (2010). Samples from HIV-
infected individuals (including recent and chronic untreated
and ART treated individuals) aligned with individuals with Ileal
Crohn’s disease across a distinct axis of variation from that
associated with diet/culture (see Figure S3 and the Supple-
mental Information).
Immune Responses to Selected Bacteria Modulated by
HIV Infection
Microbiota changes with HIV infection can have several underly-
ing causes, including (1) a compromised ability of the innate and/332 Cell Host & Microbe 14, 329–339, September 11, 2013 ª2013 Elor adaptive immune system to control commensal bacteria, (2)
the indirect selection of inflammation-tolerant versus sensitive
bacteria resulting from a chronic inflammatory state, or (3) a
loss of interaction with CD4+ T cells that produce regulatory
responses that promote tolerance of beneficial microbes.
Although the immunologic driving factors of microbiota changes
in HIV infection are likely to be complex, we began to explore
drivers of compositional differences by examining cytokine and
CD4+ T cell proliferative response to bacteria highly related to
OTUs that differed with HIV infection status using peripheral
blood mononuclear cells (PBMCs) from a separate cohort of un-
treated chronic HIV-positive and HIV-negative individuals. We
tested (1) two species from the genus Bacteroides, which had
a conserved decrease with HIV infection (Bacteroides dorei
and Bacteroides fluxus); (2) two species highly related to OTUs
that increased with HIV infection, P. copri (Prevotellaceae) and
E. biforme (Erysipelotrichaceae) (Table S2, Figure S2); and (3)
E. coli serotype O55:K59(B5), which did not change.
We first examined proinflammatory (TNF-a) and anti-inflam-
matory (IL-10) cytokines in six HIV-negative and six HIV-positive
subjects after incubating PBMCs for 24 hr with bacterial lysate.
HIV-infected subjects tended to have elevated levels of both
TNF-a and IL-10 to all bacteria in comparison with HIV-negative
controls (Figure S4). Previous studies have shown that both of
these cytokines are elevated in plasma of HIV-positive subjects
(Dutertre et al., 2012; Said et al., 2010). However, E. biforme had
a significantly higher TNF-a:IL-10 ratio (Figure 4A) in both HIV-
negative and HIV-infected subjects, indicating that it is more
proinflammatory than the other bacteria tested.
Next, we examined CD4+ T cell proliferative responses to
these bacteria in 10 subjects with HIV infection and 11 HIV-
negative controls. Because responses to gut bacteria in periph-
eral blood are often below the limit of detection directly ex vivo
(Howe et al., 2009), we labeled PBMC with Cell Trace to track
cell division and cultured the PBMC with the bacteria lysate
for 6 days. This method amplifies bacteria-specific CD4+
T cells to easily detected frequencies. All bacteria, but not
LPS, induced CD4+ T cell proliferation in both HIV-infected
and HIV-negative subjects. However, responses to B. fluxus
and B. dorei were reduced with HIV infection, while responses
to P. copri, E. biforme, and E. coli were not significantly different
(Figure 4B).
DISCUSSION
Because HIV targets central players of innate and adaptive
immunity including CD4+ T cells, monocytes, and macrophages
(McMichael et al., 2010; Mogensen et al., 2010), changes in gut
microbiota with infection support the notion that the immune
system plays an important role in shaping composition. That
immune dysfunction can cause gut microbiota changes with
concomitant health effects has been supported in mice lacking
specific components of the immune system, including TLR5,
IL-22, or the inflammasome. Compositional shifts in gut micro-
biota in these models were associated with development of
colitis (Carvalho et al., 2012; Elinav et al., 2011; Zenewicz
et al., 2013) and metabolic syndrome (Vijay-Kumar et al.,
2010), diseases that are increased in prevalence with HIV
(Knox et al., 2000; Wanke, 1999).sevier Inc.
Recent SeronegativeChronic untreated cohort Chronic treated 
Figure 2. Taxonomy Bar Charts Showing Dominance of Prevotellaceae in HIV-Infected Subjects
Families significantly different between ART-naive individuals chronically infectedwith HIV andHIV-negative controls aremarkedwith a star (p < 0.05 ANOVAwith
FDR correction; only the first time point was used for individuals who had multiple time points). Those enriched in HIV negative have a blue star, and those
enriched in HIV (Chronic) are in green. Samples from the same individual at two time points are adjacent and joined with a bridge. See Tables S2A, S2B, and S2C
for lists of discriminatory genera, families, and 97% OTUs, respectively, and Figure S2 for a phylogenetic tree relating discriminatory 97% OTUs.
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matching the control cohort for age, sex, race, and geographic
location is surprising, since studies of the macaque microbiota
in SIV infection failed to detect significant changes independent
of colitis, and yet macaques experience a similar depletion of
CD4+ T cells and inflammation in the gut compared to HIV-
infected humans (McKenna et al., 2008; Veazey et al., 1998).
This difference may be related in part to SIV infection duration
(e.g., macaques in one longitudinal study were only followed
8 weeks post infection (McKenna et al., 2008). Microbiota
changes in two of three recently infected HIV-positive humans in
our study were subtle compared to changes with chronic infec-
tion, indicating that microbiota changes begin during early infec-
tion and continue over time. In fact, a recent study, which charac-
terized gut microbial communities of six wild-living chimpanzees
fromGombeNationalPark inTanzaniawhowerenaturally infected
with SIV over the course of a 13 year survey, showed that SIV
infection was associated with increased temporal variability of
microbiota composition within individuals (Moeller et al., 2013).
However, the compositional changes observed in chimpanzees
with long-termSIV infectionwere not as consistent across individ-
uals as what we observe here in HIV-infected humans.
The similarity between gut microbiota of HIV-infected individ-
uals in the U.S. and HIV-negative individuals in agrarian cultures
suggests that the relatively strong phenotype with HIV infection
in humans may also be due to specific elements of our cohort’s
lifestyle, since Western populations appear to have a stronger
deviation of the pre- versus the post-HIV-infection microbiota.
Indeed, similar to healthy humans in agrarian cultures, theCell Host & Mhealthy gut microbiota of macaques is already Prevotella rich
and Bacteroides poor (McKenna et al., 2008). It will be of interest
to see if HIV-associated changes in agrarian cultures are less
pronounced than in the U.S. or if they are more pronounced in
macaques consuming a Western-type diet.
HIV-associated enteropathy is initiated during acute infection,
continues through advanced disease, and involves increased
intestinal inflammation (Bjarnason et al., 1996; Brenchley and
Douek, 2008). We thus had expected an expansion of bacteria
that increase with other chronic intestinal inflammatory diseases
and a decrease in diversity, which has been observed in several
unhealthy or inflammatory states (Chang et al., 2008; Willing
et al., 2010). Although a previous study that used 16S rRNA
gene quantification of order-level bacterial taxa showed a trend
toward a greater proportion with HIV infection of Enterobacter-
iales (Ellis et al., 2011), a taxon often associated with inflamma-
tory conditions (Koren et al., 2012; Mukhopadhya et al., 2012),
we did not detect significant changes in Enterobacteriales at
either coarse or fine taxonomic levels. Furthermore, microbiota
in untreated HIV infection, but not with ART, had increased diver-
sity compared to the control population. This is consistent with
the resemblance to the microbiota in agrarian cultures, which
also has increased diversity compared to that of healthy U.S.
adults (Yatsunenko et al., 2012), but not with other unhealthy
states such as inflammatory bowel disease (Willing et al., 2010)
or recurrent Clostridium difficile infection (Chang et al., 2008).
Since we excluded individuals with GI symptoms that warranted
antibiotic treatment during the preceding 30 days, we cannot
exclude the possibility that Enterobacteriales are enriched oricrobe 14, 329–339, September 11, 2013 ª2013 Elsevier Inc. 333
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Figure 3. The Fecal Microbiota of HIV-Positive Individuals in the U.S. Resemble those of HIV-Negative Individuals in Agrarian Cultures at the
Community Level
Unweighted UniFrac PCoA plot comparing data from this study with a global survey of fecal microbial community composition conducted in individuals from
Malawi, the Amazonas State of Venezuela, and the U.S. (Yatsunenko et al., 2012) (global gut) and (2) a study linking long-term dietary patterns with gut microbial
enterotypes (Wu et al., 2011) (long-term diet), using a reference mapping protocol.
(A) Points colored by study.
(B) Same plot, but with points colored across a red-blue spectrum from low to high relative abundance of the genus Bacteroides.
(C) Same as for (B), but for the Prevotella genus.
(D) Points colored by country of residence and HIV status.
See Figure S3 for an additional meta-analysis exploring the relationship of HIV infection with Crohn’s disease.
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rhea or advanced AIDS.
However, our analysis of the pro-/anti-inflammatory properties
of cultured isolates related to OTUs that increased with chronic
HIV infection indicated that E. biforme, but not P. copri, was
significantly more proinflammatory than bacteria in the HIV-
negative-associated Bacteroides genus. E. biforme is enriched
in individuals with irritable bowel syndrome (Ponnusamy et al.,
2011), and it increased in the active disease stage compared
to remission in an individual with ulcerative colitis (Harrington
et al., 2008). D. pigerwhich increased with HIV infection is signif-
icantly higher in IBD patients compared to healthy controls (Jia
et al., 2012; Loubinoux et al., 2002). Enrichment of these taxa
with HIV infection is thus consistent with the relationship we334 Cell Host & Microbe 14, 329–339, September 11, 2013 ª2013 Elobserved between HIV and Ileal Crohn’s disease in both ART-
treated and ART-untreated individuals at the community level.
Despite potential links between certain bacterial lineages and
proinflammatory states in HIV infection, overall the predominant
pattern of microbiota change with HIV infection was surprisingly
along a Prevotella-Bacteroides gradient. Prevotella- versus
Bacteroides-rich communities correlate with overall diversity
differences observed both across cultures and within Western
populations, although there is some controversy over whether
they represent discrete ‘‘enterotypes,’’ as initially proposed
(Arumugam et al., 2011), or whether this variation occurs across
a gradient (Koren et al., 2013; Wu et al., 2011; Yatsunenko et al.,
2012). Diet has been implicated as a primary driving factor of this
gradient, since Prevotella were enriched in healthy U.S. adultssevier Inc.
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Figure 4. Characterization of Immune Responses to Selected Bacteria in Untreated HIV-Positive and HIV-Negative Subjects
(A) TNF-a to IL-10 ratio (asmeasured using a bead array assay) after a 24 hr stimulation. An asterisk indicates thatE. biforme had a significantly higher TNF-a/IL-10
ratio compared to the other bacterial isolates with the Kruskal-Wallis ANOVA and Dunn test. Red signifies HIV-positive and blue HIV-negative subjects.
(B) Percentage of divided (cell trace low) CD4+ T cells enumerated by flow cytometry after a 6 day stimulation. Statistical significance was determined using
Mann-Whitney t tests. Bacteria that decreased in relative abundance with chronic, untreated HIV infection are shown in red, those that increased are in blue, and
no difference is shown in black. Points in the scatterplots depict each individual, and the bar is the median. See also Figure S4.
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and rich in carbohydrates and simple sugars (Wu et al., 2011),
and in healthy individuals in agrarian cultures with diets domi-
nated by maize-, cassava-, and other plant-derived polysaccha-
rides (De Filippo et al., 2010; Yatsunenko et al., 2012). Although
we do not have dietary information for our HIV-positive cohort
and thus do not know whether they uniformly consume a diet
that is particularly carbohydrate rich or animal fat/protein poor,
that both HIV infection duration and ART treatment had an effect
on the degree/consistency of Prevotella richness with HIV infec-
tion further supports immunologic and not strictly dietary driving
factors. This raises the intriguing possibility that the predominant
type of gut microbiota diversity variation that occurs across cul-
tures and within Western populations is driven by an interplay
between diet and the immune system.
CD4+ T cells are profoundly depleted in GALT with HIV infec-
tion (Brenchley and Douek, 2008). Interactions between CD4+
T cells and commensal gut bacteria and concomitant changes
in microbiota composition are not well understood, although
recent work has demonstrated that immunoglobulin A (IgA) is
important for maintaining balance between gut bacteria and
host (Kawamoto et al., 2012). B cell immunity and subsequent
IgA production are dependent on CD4+ T follicular helper cells
which are impaired in HIV infection (Cubas et al., 2013). Recently
it was shown that innate lympoid cells regulate CD4+ T cell re-
sponses to intestinal bacteria (Hepworth et al., 2013). CD4+
T cell-microbe interactions are perhaps best understood for
Bacteroides fragilis, which is in a genus that consistently and
dramatically decreases with HIV infection. This species, andCell Host & Mspecifically a zwitterionic polysaccharide on its capsule called
polysaccharide A (PSA), restores CD4+ T cell development in
germ-free mice by eliciting expansion of antigen-experienced
(‘‘educated’’) CD4+CD45Rblow T cells (Mazmanian et al., 2005).
B. fragilis PSA can also mediate conversion of CD4+ T cells
into anti-inflammatory Foxp3+ Treg cells (Round and Mazma-
nian, 2010) and can provide protection from inflammatory dis-
ease (Mazmanian et al., 2005, 2008).When administered as a
probiotic, another Bacteroides species,B. uniformis, can correct
T cell proliferation deficiencies displayed in ‘‘Western diet’’-fed
mice (Gauffin Cano et al., 2012) and induces higher secretion
of IL-10, a negative regulator of inflammatory response.
Given these interactions between Bacteroides species and
CD4+ T cells, it is of interest that Bacteroides decrease in HIV-
positive individuals when CD4+ T cell populations are compro-
mised, suggesting that CD4+ T cell interactions may be essential
for persistence of Bacteroides in the gut. Even within the overall
compromised T cell populations of HIV-positive subjects, we
show that proliferative responses to Bacteroides species are
preferentially depleted compared to other species tested. One
potential explanation is that CD4+ T cell responses are dimin-
ished because of reduced levels of Bacteroides antigen. How-
ever, an increased proliferative response to P. copri and
E. biforme was not observed despite their increase in relative
abundance with HIV infection, indicating that antigen con-
centration is not the only explaining factor. Another potential
explanation, given the known interaction of Bacteroides with
CD4+T cells via PSA, is that Bacteroides-specific T cells are
preferentially activated and thus killed, which is consistent withicrobe 14, 329–339, September 11, 2013 ª2013 Elsevier Inc. 335
Cell Host & Microbe
Gut Microbiota Alterations with HIV-1 Infectionenhanced HIV infection of intestinal lamina propria CD4+ T cells
generally upon exposure to commensal bacteria (Dillon et al.,
2012). Conducting immunologic assays on samples for which
we have matched gut microbiota compositional data will help
to determine the degree to which T cell proliferative response
changes may be driven by changes in antigen presence or
concentration.
Mouse experiments have supported the notion that a Bacter-
oides-poor microbiota in the context of a Western diet may have
negative health effects (Gauffin Cano et al., 2012). Oral adminis-
tration of B. uniformis to mice consuming a high-fat diet resulted
in decreased inflammation, body weight gain, liver steatosis,
liver cholesterol, and triglyceride concentrations and increased
small adipocyte numbers. In this light, it is interesting that lipo-
dystrophy, a disorder characterized by some of these same fea-
tures, has been increasingly observed in HIV-positive individuals
(Carr et al., 1998; Wanke, 1999). Although lipodystrophy and
dyslipidemia are linked to ART, particularly the protease inhibi-
tors (Carr et al., 1998), it also can occur in the absence of ART,
leading some to suggest that it is in part due to HIV infection itself
(Madge et al., 1999; Nicholaou et al., 2013).
Prevotella-rich microbiota have been linked with high plasma
levels of trimethylamine-N-oxide (TMAO), a proatherogenic car-
diovascular risk-associated compound that can be produced
from dietary L-carnitine in red meat by intestinal microbiota
(Koeth et al., 2013). Given high rates and early onset of athero-
sclerosis and coronary heart disease in HIV-infected individuals
(Boccara et al., 2013; Hsue et al., 2009), it will be of interest to see
if a Prevotella-rich microbiota in HIV-infected individuals is asso-
ciated with high TMAO levels in plasma.
The failure of ART to consistently restore the gut microbiota to
a state resembling HIV-negative individuals is consistent with
persistence of gastrointestinal diseases with ART. HIV-positive
subjects on successful ART remain at greater risk of multiple
inflammatory diseases, including atherosclerosis (Hsue et al.,
2009). Diseases of nutrition ranging from wasting to lipodystro-
phy persist, or for lipodystrophy can even be exacerbated by
ART (Carr et al., 1998; Wanke, 1999; Wanke et al., 2000).
Although ART can improve chronic diarrhea in patients with
advanced HIV infection and lead to disappearance of parasites
such as Cryptosporidium sp. from stool (Foudraine et al.,
1998), other parasites can persist (Boyles et al., 2012). A persis-
tence of an HIV-associated microbiota in some individuals on
long-term ART is also consistent with the observation that ART
treatment generally does not completely restore CD4+ T cells
in GALT (Estes et al., 2008). Discordance between CD4+ T cell
counts in GALT and the periphery may explain why we did not
observe a correlation between peripheral CD4+ T cell count
and the degree of divergence in fecal microbiota composition
from HIV-negative control samples.
It will be important to further study the effects of HIV infection
on the gut microbiota in the context of different disease states,
cultures, and diets so that the complex interactions between
lifestyle, diets, and the immune system in shaping microbiota
composition can be determined. Further studies of the immuno-
modulatory properties and inflammation tolerance of bacterial
isolates related to OTUs that change during HIV infection will
provide insight into driving factors of gut microbiota changes
and their potential impact on health.336 Cell Host & Microbe 14, 329–339, September 11, 2013 ª2013 ElEXPERIMENTAL PROCEDURES
Subject Recruitment
Four cohorts were prospectively recruited from the University of Colorado
Hospital Infectious Disease Group Practice: (1) recent HIV-1 infection, individ-
uals likely infected within the prior 6 months; (2) chronic HIV-1 infection
untreated, individuals infected for >6 months and ART drug naive or off treat-
ment for >6 months; (3) chronic HIV-1 infection on long-term ART, ART treat-
ment forR12 months with a minimum of three ART drugs prior to study entry
and viral suppressed for >6 months; and (4) healthy controls, HIV-negative
individuals matched to HIV-infected participants for sex, age, geographic
location, and smoking status (see the Supplemental Experimental Procedures
for further cohort characteristics). Individuals from cohort 2 sometimes initi-
ated ART treatment immediately following the initial visit and donated an addi-
tional fecal sample 6.7–8.5 months later. Informed consent was obtained from
each subject, and the study protocol was approved by the Colorado Multiple
Institution Review Board.
DNA Extraction and Sequencing
Stool samples were collected on a sterile swab by the patient either during or
12 hr prior to the visit and stored at80C. DNA was extracted using the stan-
dard Power Soil Kit protocol (MoBio). Extracted DNA was PCR amplified with
barcoded primers targeting the V4 region of 16S rRNA as detailed in Yatsu-
nenko et al. (2012). Control water samples that had undergone the same
DNA extraction and PCR amplification procedures were also sequenced.
Each PCR product was quantified using PicoGreen (Invitrogen), and equal
amounts (ng) of DNA from each sample were pooled and cleaned using the
UltraClean PCR Clean-Up Kit (MoBio). Sequences were generated on two
runs on a MiSeq personal sequencer (Illumina, San Diego, CA).
Sequence Data Analysis
Raw sequences were quality filtered and assigned to samples based on their
barcodes using the default parameters of QIIME version 1.5.0 (Caporaso et al.,
2010) (see the Supplemental Experimental Procedures). Sequences were
assigned to 97% ID OTUs by comparing them to a nonredundant reference
database of near-full length sequences (February 4, 2011, Greengenes data-
base) (DeSantis et al., 2006), and unassigned sequences were clustered into
de novo OTUs using UCLUSTref (Edgar, 2010). Since samples contained
between 4,694 and 72,828 sequences, analyses were standardized at 4,600
sequences per sample to avoid biases.
UniFrac PCoA analyses were conducted using QIIME as detailed in the Sup-
plemental Information. RandomForests classification on the HIV data was car-
ried out using SourceTracker software (http://sourceforge.net/projects/
sourcetracker/) (Knights et al., 2011b) and custom code as detailed in the Sup-
plemental Information. Alpha diversity was calculated using three different
measures (1) observed species, the number of 97% ID OTUs observed in
4,600 sequences; (2) Shannon Index (Shannon, 1948); and (3) PD (Faith,
1992). Only one sample was used for individuals sampled at two time points.
Bacterial families and genera in each sample were determined using the
RDP classifier retrained on the greengenes taxonomy (McDonald et al.,
2012) and statistically compared as detailed in the Supplemental Information.
Discriminating OTUs were related to each other and to bacterial type strains
using the ARB software package (Ludwig et al., 2004) as detailed in the Sup-
plemental Information.
To compare sequences from our samples to other studies, we used the
QIIME database (http://microbio.me/qiime), which assigns sequences to
97% ID OTUs by comparing them to a reference database of near-full-length
sequences (February 4, 2011, Greengenes database) (DeSantis et al., 2006)
using UCLUSTref (Edgar, 2010) as described in Lozupone et al. (2013). Unas-
signed sequenceswere dropped from the analysis.We removed samples from
individuals not between the ages of 10 and 66 and standardized at 4,600
sequences per sample.
Immunologic Assays
Bacterial lysates for B. dorei (DSM 17855), B. fluxus (DSM 22534), P. copri
(DSM18205), E. biforme (DSM 3989), and E. coli serotype O55:K59(B5) were
prepared and quantified as detailed in the Supplemental Information. PBMCs
were isolated from blood of ten untreated HIV-positive subjects with chronicsevier Inc.
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Gut Microbiota Alterations with HIV-1 Infectioninfection (median CD4+ T cells 508 cells/ml; range 248–742 and VL 55,495
copies of HIV RNA/ml; range 554–123,000) and 11 HIV-negative subjects as
described in the Supplemental Information. For the T cell proliferation assays,
PBMCs were labeled with 2 mM Cell Trace to track cell division (Invitrogen);
plated at 1 3 106 cells/ml in a 48-well plate; and cultured with 1 mg/ml of bac-
terial lysates, LPS, 2.5 mg/ml PHA, or medium alone at 37C in a humidified 5%
CO2 atmosphere. After 6 days, cells were washed with PBS containing 1%
BSA and surface stained with anti-CD4 (PE-Cy5-5; BD Biosciences), anti-
CD3 (Qdot 605; Invitrogen), anti-CD19 (Alexa Fluor 405; Caltag), CD45RA,
and CD27 for 30 min at 4C, then washed and fixed with 1% formaldehyde.
Cells were analyzed using a LSR-II flow cytometer (BD Immunocytometry Sys-
tems) as described in the Supplemental Information.
For the cytokine analysis, PBMCs (13 106 cells/ml) were cultured in 96-well
plates with 1 mg/ml of bacterial lysates, LPS, or medium alone. Cultures were
incubated at 37C in a humidified 5% CO2 atmosphere for 24 hr, and culture
supernatants were harvested and centrifuged to remove remaining cells and
stored at 80C. IL-10 and TNF-a levels were assayed using a 7-plex Inflam-
matory Cytokine kit (Meso Scale Development, Gaithersberg MD). Assays
were performed per manufacturer’s instructions and analyzed using a Sector
Imager 2400 (Meso Scale Discovery).
ACCESSION NUMBERS
The sequence data have been deposited in the QIIME database (http://www.
microbio.me/qiime/) and at EBI (http://www.ebi.ac.uk/ena/; accession
number ERP003611).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.chom.2013.08.006.
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